Kevin Gorman, CEO of Neurocrine Biosciences Inc (NASDAQ:NBIX), sold 167,858 shares of the company on January 9, 2024, according to a recent SEC Filing.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles
Home » Neurocrine Biosciences Inc CEO Kevin Gorman Sells 167,858 Shares